To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids
Status:
Unknown status
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to study the effects of GL701 on bone mineral density
in women with active systemic lupus erythematosus (SLE) who are also receiving treatment with
glucocorticoids (e.g., prednisone).